Abstract Background: Alzheimer’s Disease (ad) patients often experience clinically significant agitation, leading to distress, increased healthcare costs and earlier institutionalisation.…
Abstract Background: Studies focusing on the treatment of neuropsychiatric symptoms (NPS) in Huntington’s disease (HD) are scarce and show a…
Abstract Alzheimer’s disease (AD) is a progressive, degenerative brain disorder that impairs memory and thinking skills, leading to significant economic…
Abstract Background: Apathy is an important but unrecognised aspect of Parkinson’s disease (PD). The optimal therapeutic options for apathy remain…
Abstract Introduction: Neuropsychiatric symptoms are an integral component of the natural history of dementia, occurring from prodromal to advanced stages…
Abstract Cannabis abuse is a common public health issue and may lead to considerable adverse effects. Along with other effects,…
Abstract Alzheimer’s Dementia (AD) is a devastating neurodegenerative disease that affects approximately 17% of people aged 75–84. Neuropsychiatric symptoms (NPS)…
Abstract Background: Cannabis is commonly used for its medical properties. In particular, cannabis is purported to have beneficial effects on…
Abstract Agitation is a prevalent and difficult-to-treat symptom in patients with moderate-to-severe Alzheimer’s disease (AD). Though there are nonpharmacological and…